DE3685432D1 - Pharmazeutische loesungen die dimethylsulfoxid enthalten. - Google Patents

Pharmazeutische loesungen die dimethylsulfoxid enthalten.

Info

Publication number
DE3685432D1
DE3685432D1 DE8686301657T DE3685432T DE3685432D1 DE 3685432 D1 DE3685432 D1 DE 3685432D1 DE 8686301657 T DE8686301657 T DE 8686301657T DE 3685432 T DE3685432 T DE 3685432T DE 3685432 D1 DE3685432 D1 DE 3685432D1
Authority
DE
Germany
Prior art keywords
dimethyl sulfoxide
solutions containing
containing dimethyl
pharmaceutical solutions
skin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE8686301657T
Other languages
English (en)
Inventor
Edmund Sandborn
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
DIMETHAID RESEARCH Inc
Original Assignee
DIMETHAID RESEARCH Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by DIMETHAID RESEARCH Inc filed Critical DIMETHAID RESEARCH Inc
Application granted granted Critical
Publication of DE3685432D1 publication Critical patent/DE3685432D1/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/20—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing sulfur, e.g. dimethyl sulfoxide [DMSO], docusate, sodium lauryl sulfate or aminosulfonic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Dermatology (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
DE8686301657T 1984-05-14 1986-03-07 Pharmazeutische loesungen die dimethylsulfoxid enthalten. Expired - Fee Related DE3685432D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CA000454281A CA1236029A (en) 1984-05-14 1984-05-14 Pharmaceutical solutions comprising dimethyl sulfoxide
EP19860301657 EP0235424B1 (de) 1984-05-14 1986-03-07 Pharmazeutische Lösungen die Dimethylsulfoxid enthalten

Publications (1)

Publication Number Publication Date
DE3685432D1 true DE3685432D1 (de) 1992-06-25

Family

ID=4127865

Family Applications (1)

Application Number Title Priority Date Filing Date
DE8686301657T Expired - Fee Related DE3685432D1 (de) 1984-05-14 1986-03-07 Pharmazeutische loesungen die dimethylsulfoxid enthalten.

Country Status (5)

Country Link
US (2) US4575515A (de)
EP (1) EP0235424B1 (de)
AT (1) ATE76306T1 (de)
CA (1) CA1236029A (de)
DE (1) DE3685432D1 (de)

Families Citing this family (59)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1236029A (en) * 1984-05-14 1988-05-03 Edmund Sandborn Pharmaceutical solutions comprising dimethyl sulfoxide
GB8517299D0 (en) * 1985-07-09 1985-08-14 Salim A S M Dermatologically active substances
IT1197056B (it) * 1986-08-01 1988-11-25 Intercos Italiana Pomata per mascherare difetti della pelle e cicatrici
DE3632359A1 (de) * 1986-09-24 1988-04-07 Troponwerke Gmbh & Co Kg Arzneimittelzubereitungen
DE3706421A1 (de) * 1987-02-27 1988-09-08 Robugen Gmbh Arzneimittel zur behandlung viraler erkrankungen
WO1989005660A1 (en) * 1987-12-23 1989-06-29 Poltavsky Meditsinsky Stomatologichesky Institut Pharmaceutical preparation for individual prophylaxis of venereal diseases and curing urogenital trichomoniasis
US5059603A (en) * 1989-06-12 1991-10-22 Centuries Laboratories, Inc. Method and composition for treating impotence
US5061724A (en) * 1989-07-18 1991-10-29 Sheldon Gertner Method for treating arthritically inflamed body joints, particularly joints having gouty arthritis
US5091379A (en) * 1989-08-31 1992-02-25 Du Pont Merck Pharmaceutical Company Topical antinflammatory compositions with minimal systemic absorption
EP0711181A1 (de) * 1993-07-28 1996-05-15 Pfizer Inc. Behandlung der psoriasis
US6113893A (en) * 1993-07-28 2000-09-05 Pfizer Inc. Psoriasis treatment
US5665378A (en) * 1994-09-30 1997-09-09 Davis; Roosevelt Transdermal therapeutic formulation
US6492420B2 (en) 1995-03-10 2002-12-10 Photocure As Esters of 5-aminolevulinic acid as photosensitizing agents in photochemotherapy
US7530461B2 (en) * 1995-03-10 2009-05-12 Photocure Asa Esters of 5-aminolevulinic acid as photosensitizing agents in photochemotherapy
US6992107B1 (en) 1995-03-10 2006-01-31 Photocure Asa Esters of 5-aminolevulinic acid and their use as photosensitizing compounds in photochemotherapy
CA2215069C (en) * 1995-03-10 2006-09-12 Photocure As Esters of 5-aminolevulinic acid as photosensitizing agents in photochemotherapy
GB9700396D0 (en) 1997-01-10 1997-02-26 Photocure As Photochemotherapeutic compositions
US20040121023A1 (en) * 1998-11-02 2004-06-24 Victor Stevens Composition to alleviate pain and topical method of applying same
US6159977A (en) * 1998-11-16 2000-12-12 Astan, Inc. Therapeutic anti-fungal nail preparation
US20040048376A1 (en) * 2000-04-10 2004-03-11 Benoit Chabot Methods for modulating splicing and/or alternative splicing, and for identifying alternatively spliced units in genes
GB0018528D0 (en) 2000-07-27 2000-09-13 Photocure Asa Compounds
GB0018527D0 (en) * 2000-07-27 2000-09-13 Photocure Asa Composition
WO2004014903A1 (en) 2002-08-02 2004-02-19 Ab Science 2-(3-aminoaryl)amino-4-aryl-thiazoles and their use as c-kit inhibitors
US8450302B2 (en) * 2002-08-02 2013-05-28 Ab Science 2-(3-aminoaryl) amino-4-aryl-thiazoles and their use as c-kit inhibitors
US20040126343A1 (en) * 2002-12-26 2004-07-01 Garshowitz Solomon David Nail drug delivery
US7132452B2 (en) * 2003-03-10 2006-11-07 Fang-Yu Lee Topical formulation having effects on alleviating pain/inflammation caused by herpes virus infection
EP1684750B1 (de) * 2003-10-23 2010-04-28 AB Science 2-aminoaryloxazol-verbindungen als tyrosinkinase-hemmer
US20060223788A1 (en) * 2005-03-29 2006-10-05 Cathcart Clifton H Analgesic composition for topical use
NZ563097A (en) 2005-04-04 2011-11-25 Ab Science Substituted oxazole derivatives and their use as tyrosine kinase inhibitors
US20100087546A1 (en) * 2005-04-20 2010-04-08 Biogenic Innovations, Llc Use of dimethyl sulfone (msm) to reduce homocysteine levels
US20060281822A1 (en) * 2005-04-20 2006-12-14 Cardinal Associates, Inc. Treatment and prevention of elevated homocysteine
CN101296691B (zh) * 2005-08-05 2011-07-27 努沃研究公司 透皮释药剂型
AU2006291134C1 (en) 2005-09-12 2013-08-15 Abela Pharmaceuticals, Inc. Systems for removing dimethyl sulfoxide (DMSO) or related compounds, or odors associated with same
US8435224B2 (en) 2005-09-12 2013-05-07 Abela Pharmaceuticals, Inc. Materials for facilitating administration of dimethyl sulfoxide (DMSO) and related compounds
EP1937286B1 (de) 2005-09-12 2016-03-09 Abela Pharmaceuticals, Inc. Zusammensetzungen aus dimethylsulfoxid (dmso)
US8480797B2 (en) * 2005-09-12 2013-07-09 Abela Pharmaceuticals, Inc. Activated carbon systems for facilitating use of dimethyl sulfoxide (DMSO) by removal of same, related compounds, or associated odors
ITLO20060004A1 (it) * 2006-08-08 2008-02-09 River Pharma Srl "lapille" e una nuova invenzione avente per oggetto una nuova combinazione chimica stabile per uso cosmetico e farmaceutico contenente come ingredienti attivi l'acido alfa-lipoico ed il dimetilsulfossido, in grado di migliorare l'assorbimento, la bio
MX2009004038A (es) 2006-10-17 2009-08-24 Nuvo Res Gel de diclofenaco.
US20100254965A1 (en) * 2006-10-24 2010-10-07 Board Of Regents ,The University Of Texas System Adenosine Signaling in Diagnosis, Treatment, and Prevention of Priapism and Erectile Dysfunction
CN101790370B (zh) 2007-06-08 2013-06-12 特罗伊卡药品有限公司 一种新的双氯芬酸非水局部用溶液及其制备方法
US20100100060A1 (en) * 2008-10-17 2010-04-22 Novartis Ag Applicator for pharmaceutical product and method of using same
BRPI0921494A2 (pt) * 2008-11-03 2018-10-30 Prad Reasearch And Development Ltd método de planejamento de uma operação de amostragem para uma formação subterrãnea, método de contolar uma operação de amostragem de formação subterrânea, método de controlar uma operação de perfuração para uma formação subterrãnea, e método de realizar uma amostragem durante a operação de perfuração.
US8618164B2 (en) 2009-03-31 2013-12-31 Nuvo Research Inc. Treatment of pain with topical diclofenac compounds
US8546450B1 (en) 2009-03-31 2013-10-01 Nuvo Research Inc. Treatment of pain with topical diclofenac compounds
US20110092597A1 (en) * 2009-10-21 2011-04-21 Fangchen Lee Method for treating herpes virus infection
US9855212B2 (en) 2009-10-30 2018-01-02 Abela Pharmaceuticals, Inc. Dimethyl sulfoxide (DMSO) or DMSO and methylsulfonylmethane (MSM) formulations to treat infectious diseases
JP5734313B2 (ja) 2010-01-12 2015-06-17 アーべー・シオンス チアゾールおよびオキサゾールキナーゼ阻害剤
US20120302577A1 (en) 2010-01-28 2012-11-29 Ab Science Treatment of gist with masitinib
EP2544662B1 (de) 2010-03-10 2020-05-20 Nuvo Pharmaceuticals Inc. Schäumbare formulierung
MX345458B (es) 2011-05-11 2017-02-01 Veloce Biopharma Llc Composiciones antimicoticas para el tratamiento de piel y uñas.
US9168245B2 (en) 2011-07-27 2015-10-27 Ab Science Selective protein kinase inhibitors
US10813897B2 (en) * 2011-12-27 2020-10-27 Cmpd Licensing, Llc Composition and method for compounded therapy
CA2864910C (en) 2012-02-17 2018-07-24 Joseph CAPRIOTTI Antifungal compositions for the treatment of skin and nails
US20140113970A1 (en) 2012-10-22 2014-04-24 Mallinckrodt LLC Covidien Dispensing system
WO2015144614A1 (en) 2014-03-24 2015-10-01 Ab Science Diazaspiroalkaneone-substituted oxazole derivatives as spleen tyrosine kinase inhibitors
CA2973725A1 (en) 2015-01-20 2016-07-28 Veloce Biopharma Llc Novel iodophor composition and methods of use
EP3053920B1 (de) 2015-02-05 2020-04-08 AB Science Verbindungen mit antitumoraktivität
EP3144307A1 (de) 2015-09-18 2017-03-22 AB Science Neue oxazol derivaten als syk kinasehemmer
US10716754B2 (en) 2016-03-28 2020-07-21 Tioga Research, Inc. Topical formulation

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE644613A (de) * 1963-12-09 1964-07-01
US3549770A (en) * 1963-12-09 1970-12-22 Crown Zellerbach Corp Therapeutic administration of effective amounts of dimethyl sulfoxide to human and animal subjects
CA1001075A (en) * 1963-12-09 1976-12-07 Stanley W. Jacob Pharmaceutical compositions containing dialkyl sulfoxides
US3740420A (en) * 1967-11-28 1973-06-19 Crown Zellerbach Corp Pharmaceutical compositions with dimethyl sulfoxide
US3551554A (en) * 1968-08-16 1970-12-29 Crown Zellerbach Corp Enhancing tissue penetration of physiologically active agents with dmso
US3711602A (en) * 1970-10-30 1973-01-16 Crown Zellerbach Corp Compositions for topical application for enhancing tissue penetration of physiologically active agents with dmso
US3743727A (en) * 1970-11-16 1973-07-03 Crown Zellerbach Corp Enhancing tissue penetration of certain antimicrobial agents with dimethyl sulfoxide
EP0051163A3 (de) * 1980-11-03 1983-02-16 Dr. Franz Köhler Chemie KG Intramuskulär schmerzlos anwendbare 4-Dimethylaminophenol Hydrochlorid-Lösung und Verfahren zu deren Herstellung
US4353896A (en) * 1981-06-08 1982-10-12 Levy Michael A Penetrating topical medicament
US4369190A (en) * 1981-06-23 1983-01-18 Schulte Thomas L Analgesic composition and use thereof to ameliorate intractable pain
GR81250B (en) * 1983-12-22 1985-11-19 American Home Prod Menthol enhancement of transdermal drug delivery
CA1236029A (en) * 1984-05-14 1988-05-03 Edmund Sandborn Pharmaceutical solutions comprising dimethyl sulfoxide

Also Published As

Publication number Publication date
US4575515A (en) 1986-03-11
EP0235424A1 (de) 1987-09-09
US4652557A (en) 1987-03-24
ATE76306T1 (de) 1992-06-15
CA1236029A (en) 1988-05-03
EP0235424B1 (de) 1992-05-20

Similar Documents

Publication Publication Date Title
DE3685432D1 (de) Pharmazeutische loesungen die dimethylsulfoxid enthalten.
DE3583799D1 (de) Feste zubereitung mit langsamer freisetzung.
KR950700722A (ko) 피부 보호 방법 및 그 조성물(Skin Care Method and Composition)
DE3884081D1 (de) Anti-Akne-Zusammensetzung.
NO854943L (no) Fremgangsmaate for fremstilling av en topisk, antibakteriell krem (salve).
DE3579337D1 (de) Dermatologische fungizide loesung.
DK0582239T3 (da) Farmaceutisk og/eller kosmetisk formulering
DE69315927D1 (de) Kosmetische Zusammensetzung, die einen Lipidstoff und eine Hydroxy - oder Ketofettsäure enthält
IS3284A7 (is) Aðferð við framleiðslu á N1-súbstitúeruðum bensimidasólafleiðum til að nota við lækningar
SE503436C2 (sv) Pyroglutamidderivat
PT92647A (pt) Processo para a preparacao de 5-cloro-2-< { (3,4-dimetoxi-2-piridinil)-metil}-sulfinil>-1h-benzimidazol e de composicoes farmaceuticas que o contem
ES2189961T3 (es) Un ensayo de diagnostico para la esquizofrenia que emplea niacina.
DE3762018D1 (de) Abwaschbare topische zubereitung zur therapie der psoriasis.
ATE98868T1 (de) Topisch kosmetisch anzuwendende depolymerisierte nukleinsaeuren enthaltende arzneizubereitungen.
ES2159983T3 (es) Composicion que contiene urea y sus utilizaciones en el ambito cosmetico y/o dermatologico.
BR8906608A (pt) Composicao para o combate sistemico de ectoparasitas em hospedeiros,processo para a preparacao de compostos,sua aplicacao,medicamento veterinario e processo para o combate sistemico de ectoparasitas em hospedeiros
SE8902458L (sv) Laekemedelskomposition
BR0012775A (pt) Comprimido de microgrânulos com baixa dosagem de princìpio ativo contendo um diluente diretamente compressìvel, composição, e, processo de preparação do comprimido
DE3877365D1 (de) Arzneimittel mit methylcellulose.
ATE120959T1 (de) Wasserlösliche vitamin a-zubereitungen und deren verwendung bei der hautbehandlung.
BR8904508A (pt) Composto,processo para sua preparacao,composicao e processo para o combate ou prevencao de doencas em plantas e aplicacao
KR900016130A (ko) 2-피리딜메틸티오 유도체 및 궤양 치료제
KR900012622A (ko) 피부질환치료 조성물
ATE46083T1 (de) Arzneimittel zur topischen anwendung.
DE59001796D1 (de) Verwendung einer hydroxyoctadecadiensaeure, deren zur ketoform oxidierte saeure sowie deren derivate zur therapie oestrogenabhaengiger krankheiten, sowie pharmazeutische zusammensetzungen, die diese enthalten.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee